Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41579-020-00461-z http://scihub22266oqcxt.onion/10.1038/s41579-020-00461-z 33057203!7556561!33057203     free     free     free       Nat+Rev+Microbiol 2021 ; 19 (3): 171-183 Nephropedia Template TP {{tp|p=33057203|t=2021. Considerations for diagnostic COVID-19 tests |pdf=|usr=}}{{33057203}} gab.com Text Considerations for diagnostic COVID-19 tests JO: Nat Rev Microbiol http://www.kidney.de/pget.php?&tw=1&pmid=33057203 #FOAvip During the early phase of the coronavirus disease 2019 (COVID-19) pandemic, design, development, validation, verification and implementation of diagnostic tests were actively addressed by a large number of diagnostic test manufacturers. Hundreds of molecular tests and immunoassays were rapidly developed, albeit many still await clinical validation and formal approval. In this Review, we summarize the crucial role of diagnostic tests during the first global wave of COVID-19. We explore the technical and implementation problems encountered during this early phase in the pandemic, and try to define future directions for the progressive and better use of (syndromic) diagnostics during a possible resurgence of COVID-19 in future global waves or regional outbreaks. Continuous global improvement in diagnostic test preparedness is essential for more rapid detection of patients, possibly at the point of care, and for optimized prevention and treatment, in both industrialized countries and low-resource settings. Twit Text FOAVip Considerations for diagnostic COVID-19 tests ????Nat Rev Microbiol http://www.kidney.de/pget.php?&tw=1&pmid=33057203 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33057203 #FOAvip English Wikipedia <ref>{{Cite pmid|33057203}}</ref> Considerations for diagnostic COVID-19 tests #MMPMID33057203 Vandenberg O; Martiny D; Rochas O; van Belkum A; Kozlakidis Z Nat Rev Microbiol 2021[Mar]; 19 (3): 171-183 PMID33057203show ga During the early phase of the coronavirus disease 2019 (COVID-19) pandemic, design, development, validation, verification and implementation of diagnostic tests were actively addressed by a large number of diagnostic test manufacturers. Hundreds of molecular tests and immunoassays were rapidly developed, albeit many still await clinical validation and formal approval. In this Review, we summarize the crucial role of diagnostic tests during the first global wave of COVID-19. We explore the technical and implementation problems encountered during this early phase in the pandemic, and try to define future directions for the progressive and better use of (syndromic) diagnostics during a possible resurgence of COVID-19 in future global waves or regional outbreaks. Continuous global improvement in diagnostic test preparedness is essential for more rapid detection of patients, possibly at the point of care, and for optimized prevention and treatment, in both industrialized countries and low-resource settings. |*COVID-19 Testing/economics/methods/standards[MESH] |COVID-19/diagnosis[MESH] |Developed Countries[MESH] |Developing Countries[MESH] |Diagnostic Test Approval[MESH] |Humans[MESH] |Manufacturing Industry[MESH] |Pandemics[MESH] |Point-of-Care Testing[MESH] |SARS-CoV-2/genetics/*isolation & purification[MESH] |Time Factors[MESH]Considerations for diagnostic COVID-19 tests (epmc).pdf DeepDyve Pubget Overpricing